<DOC>
	<DOCNO>NCT00698789</DOCNO>
	<brief_summary>Determine effect treatment INCB019602 administer add-on stable dose metformin therapy type 2 diabetic subject safety glycemic control .</brief_summary>
	<brief_title>Evaluate Safety Tolerability INCB019602 When Administered With Metformin Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Established diagnosis T2D Currently take metformin monotherapy stable dose level FPG 150 270 mg/dL History clinical manifestation renal impairment Hyperglycemia &gt; 270 mg/dL Receiving thiazolidenediones , Exenatide sulfonylureas within 90 day prior screen Prior use Acipimox know name Olbetam within 90 day prior screen . Diagnosed major depression within last 2 year require hospitalization History chronic insulin therapy glycemic control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>